P

Priovant Therapeutics

Clinical-stage biotech delivering autoimmune therapies

Manager/Senior Manager - Clinical Development

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeDurham, NC, USANo salary listed

About the Job

Requirements

  • Completed a US-based Doctor of Pharmacy or Doctor of Philosophy degree program in Pharmacokinetics, Pharmacology, Pharmaceutics, Biomedical Engineering, or a related field.
  • Experience as a laboratory assistant, research assistant, or other prior relevant internship or work research experience.
  • Eligibility to work in the United States for the duration of employment.

Responsibilities

  • Assist in the creation of clinical development strategies for Priovant assets.
  • Understand and participate in the design, analysis, and interpretation of clinical studies.
  • Assist in drafting study-related and regulatory documents.
  • Assist the clinical team in the set-up, conduct, and oversight of clinical studies.
  • Perform exploratory quantitative analyses using nonclinical and clinical data.
  • Perform literature reviews and benchmarking analyses to aid decision making.
  • Participate directly in cross-functional project team activities and make meaningful contributions to research programs for investigational drugs.

Desired Qualifications

  • Completed post-graduate fellowship or similar, or 1 to 2 years of employment in the pharmaceutical industry or a related field.

About the Company

Priovant Therapeutics

Clinical-stage biotech delivering autoimmune therapies

Priovant Therapeutics focuses on developing medicines for autoimmune diseases that carry the heaviest patient burden. It is in the clinical-stage phase, building a pipeline of therapies that specifically target the molecular problems driving severe autoimmune conditions. This approach aims to address patients who are underserved by current treatments. The company’s treatments work by focusing on the underlying molecular dysregulations to reduce disease activity and improve outcomes, rather than broadly suppressing the immune system. Priovant differentiates itself by prioritizing severe, underserved autoimmune diseases and pursuing targeted, mechanism-based therapies rather than one-size-fits-all drugs. The goal is to bring new, effective options to patients who lack good treatment choices and to move promising therapies through clinical development toward patient access.

Company size
51-200
Company stage
Not listed
Total funding
Not listed
Headquarters
New York City, United States
Founded
Not listed

Recently Posted Jobs

Explore more opportunities at Priovant Therapeutics

See more jobs